Skip to content
10-Q

Quarterly Report

PROTALIX BIOTHERAPEUTICS, INC. PLX

0001558370-25-011471

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 79.73M sh
Shares Diluted Q2 2025 · Jun 30, 2025 81.27M sh
Shares Diluted Q2 2025 · Jun 30, 2025 77.65M sh
Shares Diluted Q2 2025 · Jun 30, 2024 73.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 73.17M sh
Capex Q2 2025 · Jun 30, 2025 $737K
Capex Q2 2025 · Jun 30, 2024 $770K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$10.29M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $578K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $17.9M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $19.76M
Stockholders Equity Q2 2025 · Jun 30, 2025 $49.9M
Stockholders Equity Q2 2025 · Mar 31, 2025 $45.21M
Stockholders Equity Q2 2025 · Dec 31, 2024 $43.21M
Stockholders Equity Q2 2025 · Jun 30, 2024 $28.58M
Stockholders Equity Q2 2025 · Mar 31, 2024 $29.79M
Stockholders Equity Q2 2025 · Dec 31, 2023 $33.57M
Current Liabilities Q2 2025 · Jun 30, 2025 $24.09M
Current Liabilities Q2 2025 · Dec 31, 2024 $25.62M
Total Liabilities Q2 2025 · Jun 30, 2025 $28.58M
Total Liabilities Q2 2025 · Dec 31, 2024 $30.21M
Current Assets Q2 2025 · Jun 30, 2025 $65.49M
Current Assets Q2 2025 · Dec 31, 2024 $60.08M
Total Assets Q2 2025 · Jun 30, 2025 $78.49M
Total Assets Q2 2025 · Dec 31, 2024 $73.42M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.04
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.03
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.09
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 −$0.04
Eps Basic Q2 2025 · Jun 30, 2024 −$0.03
Eps Basic Q2 2025 · Jun 30, 2024 −$0.09
Sga Expense Q2 2025 · Jun 30, 2025 $2.62M
Sga Expense Q2 2025 · Jun 30, 2025 $5.23M
Sga Expense Q2 2025 · Jun 30, 2024 $3.48M
Sga Expense Q2 2025 · Jun 30, 2024 $6.6M
Rd Expense Q2 2025 · Jun 30, 2025 $5.99M
Rd Expense Q2 2025 · Jun 30, 2025 $9.47M
Rd Expense Q2 2025 · Jun 30, 2024 $2.96M
Rd Expense Q2 2025 · Jun 30, 2024 $5.85M
Net Income Q2 2025 · Jun 30, 2025 $164K
Net Income Q2 2025 · Jun 30, 2025 −$3.46M
Net Income Q2 2025 · Jun 30, 2024 −$2.2M
Net Income Q2 2025 · Jun 30, 2024 −$6.8M
Operating Income Q2 2025 · Jun 30, 2025 $1.17M
Operating Income Q2 2025 · Jun 30, 2025 −$2.97M
Operating Income Q2 2025 · Jun 30, 2024 −$2.43M
Operating Income Q2 2025 · Jun 30, 2024 −$7.28M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $5.87M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $14.05M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $9.46M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $12.06M
Revenue Q2 2025 · Jun 30, 2025 $15.66M
Revenue Q2 2025 · Jun 30, 2025 $25.77M
Revenue Q2 2025 · Jun 30, 2024 $13.47M
Revenue Q2 2025 · Jun 30, 2024 $17.22M